(Q42678700)

4 November 2017

Meal-induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide (English)

1 reference

4 November 2017

1 reference

3

1 reference

4 November 2017

2

Ostenson CG

1 reference

4 November 2017

Yngen M

1

1 reference

PubMed ID

16433710

4 November 2017

Wallén NH

series ordinal

4

1 reference

4 November 2017

1 February 2006

1 reference

4 November 2017

1 reference

4 November 2017

23

1 reference

4 November 2017

2

1 reference

4 November 2017

134-140

1 reference

Atherothrombosis, inflammation, and diabetes

4 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01765.X

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01765.X

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01765.X

Post-load hyperglycaemia-an inappropriate therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01765.X

Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01765.X

Acute hyperglycemia increases soluble P-selectin in male patients with mild diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01765.X

Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01765.X

Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01765.X

Optimization of an enzyme immunoassay for 11-dehydro-thromboxane B(2) in urine: comparison with GC-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01765.X

An ordinary mixed meal transiently impairs endothelium-dependent vasodilation in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01765.X

The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01765.X

Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01765.X

Antiaggregatory activity of hypoglycaemic sulphonylureas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01765.X

The effect of repaglinide on insulin secretion and oxidative stress in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01765.X

The post-prandial state in Type 2 diabetes and endothelial dysfunction: effects of insulin aspart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01765.X

10.1111/J.1464-5491.2005.01765.X

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference

PubMed ID

16433710